AERIE PHARMACEUTICAL

AERI
Delayed Quote. Delayed  - 10/15 04:00:00 pm
13.23USD -0.75%

Turn to zoom
Prev.13.3300
Open13.4600
High13.5000
Low13.0950
Volume351 990
Latest news
5d ago
5d ago
5d ago
5d ago
Chart AERIE PHARMACEUTICALS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishNeutral
Resistance14,214,220,9
Spread/Res.-6,6%-6,6%-37%
Spread/Supp.17%17%25%
Support11,311,310,6
Financials
Sales 2021 112 M - -
Net income 2021 -156 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,30x
Yield 2021 -
Capitalization 625 M 625 M -
Capi. / Sales 2021 5,60x
Capi. / Sales 2022 3,81x
Nbr of Employees 365
Free-Float 97,5%
Company
Aerie Pharmaceuticals, Inc. is an ophthalmic pharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases. The Company’s commercial products...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-11-10 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 13,23 $
Average target price 25,45 $
Spread / Average Target 92,4%